In addition to EBV-positive Burkitt lymphoma cells, we also demonstrated that CMER and GCV combination kills EBV-positive gastric cancer and nasopharyngeal carcinoma cells (Fig. 6D, E, and 7). The gene discussed is MERTK; the disease is Burkitt lymphoma.